Creative Biolabs integrates the latest advances and scientific reports in the field of stem cells and puts them in a podcast column for interested researchers.

Creative Biolabs integrates the latest advances and scientific reports in the field of stem cells and puts them in a podcast column for interested researchers.

Creative Biolabs integrates the latest advances and scientific reports in the field of stem cells and puts them in a podcast column for interested researchers.

Creative Biolabs integrates the latest advances and scientific reports in the field of stem cells and puts them in a podcast column for interested researchers.

Creative Biolabs integrates the latest advances and scientific reports in the field of stem cells and puts them in a podcast column for interested researchers.

Stem cells are the source materials from which all other cells are differentiated. It is believed that stem cells hold the key to the future of regenerative medicine. Moreover, the advancement of cell engineering technology has also greatly expanded the therapeutic potential of stem cells. Here, Creative Biolabs will introduce the basics about stem cells and their broad applications.

This episode   focuses on advances in broadening the repertoire of available donor sources,   including the generation of virus-specific T cells from virus-naïve   individuals and the use of third-party donors.

This episode   focuses on the introduction to Epstein-Barr virus and Epstein-Barr   virus-specific T cells, as well as advances in the development of   multi-virus-specific T cells.

This episode   focuses on obstacles and corresponding strategies in allogeneic hematopoietic   cell transplantation, and the progress in generating cytomegalovirus-specific   T cells.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.